ABSTRACT
About Transplantation
Transplantation is a procedure wherein diseased or injured cells, tissues, or organs are replaced with healthy cells, tissues, or organs to restore normal functioning of the body. Donor and recipient cells, tissues, and organs should match or be compatible, or can lead to transplant rejection. The surface of the transplanted organs contains antigens, which the recipient's immune system may not adapt to. This can lead to rejection of an organ. Hence, serological and human leukocyte antigen (HLAs) tests are conducted to help identify the antigens and help in successful organ transplantation. With HLA testing, immunosuppressive drugs are provided to minimize graft rejection. In humans, major histocompatibility complex controlled by the genes located on chromosome 6 is responsible for ensuring compatibility between donors and recipients.
Technavio’s analysts forecast the global transplantation market to grow at a CAGR of 9.76% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global transplantation market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various types of products, which are used for treatment purposes.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Transplantation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Bio-Rad Laboratories
• Illumina
• Thermo Fisher Scientific
Other prominent vendors
• Abbott Laboratories
• Acelity
• Avioq
• AxoGen
• BD
• BioLifeSolutions
• CARMAT
• CareDx
• Chronix Biomedical
• Dr. Franz Köhler Chemie
• GenDx
• HistoGenetics
• Luminex
• Miromatrix Medical
• Medipex
• Nano Dimension
• Organovo
• Ortho Clinical Diagnostics
• Oxford Immunotec
• Pacific Biosciences of California
• Pandorum Technologies
• Qiagen
• Roche
• Siemens Healthineers
• SynCardia
• Transplant Biomedicals
• XVIVO Perfusion
Market driver
• M&A between small specialized hospitals and tier-1 hospitals.
• For a full, detailed list, view our report
Market challenge
• High cost of transplant and unfavorable reimbursement scenario.
• For a full, detailed list, view our report
Market trend
• Government initiatives on transplant research programs.
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Research Methodology
PART 03: Introduction
• Key market highlights
• Overview of organ transplantation
• Overview of global transplantation market
PART 04: Market landscape
• Market overview
• Five forces analysis
PART 05: Market segmentation by product
• Global transplantation market by tissue products
• Global transplantation market by organ preservation solutions
• Global transplantation market by other transplantation products
• Global transplantation market by transplant diagnostics
PART 06: Market segmentation by procedures
• Global kidney transplantation market
• Global liver transplantation market
• Global heart transplantation market
• Global lung transplantation market
• Global pancreas transplantation market
• Global other transplantation market
PART 07: Market segmentation by end-user
• Hospitals and transplant centers
• Donor registries and research laboratories
PART 08: Geographical segmentation
• Transplantation market in Americas
• Transplantation market in EMEA
• Transplantation market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments
PART 11: Market trends
• Government initiatives on transplant research programs
• Emergence of 3D bioprinting
• Paradigm shift toward liquid biopsy
• Increase in M&A
PART 12: Vendor landscape
• Competitive landscape
PART 13: Key vendor analysis
• Bio-Rad Laboratories
• Illumina
• Thermo Fisher Scientific
• Key companies to watch
• Other prominent vendors
PART 14: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Kidney transplantation: Number of deceased and living donors in 2014
Exhibit 02: Liver transplantation: Number of deceased and living donors in 2014
Exhibit 03: Global transplantation market 2016-2021 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Market overview: Global transplantation market by tissue products
Exhibit 06: Global tissue products market 2016-2021 ($ billions)
Exhibit 07: Market overview: Global transplantation market by organ preservation solutions
Exhibit 08: Global transplantation market by organ preservation solutions 2016-2021 ($ millions)
Exhibit 09: Market overview: Global transplantation market by other transplantation products
Exhibit 10: Global transplantation market by other transplantation products 2016-2021 ($ billions)
Exhibit 11: Transplant diagnostics market: Serological testing and HLA typing 2016-2021 ($ millions)
Exhibit 12: Future focus: Transplant diagnostics market
Exhibit 13: Global HLA testing market 2016-2021 ($ millions)
Exhibit 14: Global serological testing market 2016-2021 ($ millions)
Exhibit 15: Global transplantation market segmentation by procedures in 2016
Exhibit 16: Market overview: Global kidney transplantation market
Exhibit 17: Market overview: Global liver transplantation market
Exhibit 18: Market overview: Heart transplantation
Exhibit 19: Global transplantation market by end-users 2016
Exhibit 20: Global transplantation market by geography 2016 and 2021 ($ billions)
Exhibit 21: Market overview: Transplantation market in Americas
Exhibit 22: Transplantation market in Americas 2016-2021 ($ billions)
Exhibit 23: Transplantation market in Americas: Market analysis of various countries
Exhibit 24: Types of transplants in US 2015
Exhibit 25: Market overview: Transplantation market in the US
Exhibit 26: Market overview: Transplantation market in Europe
Exhibit 27: Increase in number of donors for kidney transplantation in Europe 2010-2014
Exhibit 28: Transplantation market in EMEA 2016-2021 ($ billions)
Exhibit 29: Transplantation market in EMEA: Market analysis in various countries
Exhibit 30: Market overview: Transplantation market in UK
Exhibit 31: Market overview: Transplantation market in APAC
Exhibit 32: Transplantation market in APAC 2016-2021 ($ billions)
Exhibit 33: Transplantation market in APAC: Market analysis of various countries
Exhibit 34: Market overview: Transplantation market in Australia
Exhibit 35: Market impact analysis: Technology advances
Exhibit 36: Number of hospitals in US that were part of M&A 2010-2015
Exhibit 37: Impact of drivers
Exhibit 38: Average cost of transplantation procedures
Exhibit 39: Average cost of sequencers by different companies
Exhibit 40: People waiting for organ transplantation 2016
Exhibit 41: Complications specific to organs
Exhibit 42: Legal and ethical issues in countries
Exhibit 43: Impact of challenges
Exhibit 44: Competitive structure analysis of global transplantation market 2016
Exhibit 45: Competitive landscape of global transplantation market 2016
Exhibit 46: Strategies for large and small companies in global transplantation market
Exhibit 47: Bio-Rad Laboratories: Strength assessment
Exhibit 48: Bio-Rad Laboratories: Strategy assessment
Exhibit 49: Bio-Rad Laboratories: Opportunity assessment
Exhibit 50: Illumina: Strength assessment
Exhibit 51: Illumina: Strategy assessment
Exhibit 52: Illumina: Opportunity assessment
Exhibit 53: Thermo Fisher Scientific: Strength assessment
Exhibit 54: Thermo Fisher Scientific: Strategy assessment
Exhibit 55: Thermo Fisher Scientific: Opportunity assessment
